Company intelligence / Profile preview

银杏树药业

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Ginkgotree Pharmaceuticals is a clinical-stage biopharmaceutical company based in Beijing, China, specializing in the discovery and development of innovative small molecule antiviral therapies. The company's primary focus is on treating chronic viral infections, including Hepatitis C (HCV), Hepatitis B (HBV), and HIV, as well as respiratory viruses like influenza. Its pipeline features several direct-acting antivirals (DAAs) such as NS5A and NS3/4A inhibitors designed for combination regimens. Ginkgotree aims to provide high-quality, affordable treatment options for the Chinese market and beyond. The company was founded by industry veterans with extensive experience in global pharmaceutical R&D.

Therapeutic areas: Infectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on 银杏树药业.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 银杏树药业.

Explore the full profile